SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The primate lentivirus auxiliary protein Vpx counteracts an unknown restriction factor that renders human dendritic and myeloid cells largely refractory to HIV-1 infection. Here we identify SAMHD1 as this restriction factor. SAMHD1 is a protein involved in Aicardi-Goutières syndrome, a genetic encephalopathy with symptoms mimicking congenital viral infection, that has been proposed to act as a negative regulator of the interferon response. We show that Vpx induces proteasomal degradation of SAMHD1. Silencing of SAMHD1 in non-permissive cell lines alleviates HIV-1 restriction and is associated with a significant accumulation of viral DNA in infected cells. Concurrently, overexpression of SAMHD1 in sensitive cells inhibits HIV-1 infection. The putative phosphohydrolase activity of SAMHD1 is probably required for HIV-1 restriction. Vpx-mediated relief of restriction is abolished in SAMHD1-negative cells. Finally, silencing of SAMHD1 markedly increases the susceptibility of monocytic-derived dendritic cells to infection. Our results demonstrate that SAMHD1 is an antiretroviral protein expressed in cells of the myeloid lineage that inhibits an early step of the viral life cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, sterile alpha motif and HD domain 1 (SAMHD1) inhibits reverse transcription by depleting the cellular pool of deoxynucleotide triphosphates [63,64]”
From HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This approach was necessary because PU.1 is the master transcriptional regulator necessary for macrophage differentiation and silencing PU.1 prior to infection results in a change in the cellular phenotype that causes resistance to HIV infection72,73.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Rice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., Fuller, J. C., Jackson, R. M., Lamb, T., Briggs, T. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.373 · Cited by 689
A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells
Manel, N., Hogstad, B., Wang, Y., Levy, D. E., Unutmaz, D., & Littman, D. R. (2010) · Nature · doi:10.1038/nature09337 · Cited by 427
Sobhian, B., Laguette, N., Yatim, A., Nakamura, M., Levy, Y., Kiernan, R., & Benkirane, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.04.012 · Cited by 381
Self-citationBlanchet, F. P., Moris, A., Nikolic, D. S., Lehmann, M., Cardinaud, S., Stalder, R., Garcia, E., Dinkins, C., Leuba, F., Wu, L., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.011 · Cited by 295
Self-citationImmunoaffinity Purification of Mammalian Protein Complexes
Nakatani, Y., & Ogryzko, V. (2003) · Methods in Enzymology · doi:10.1016/s0076-6879(03)70037-8 · Cited by 283
DCs and NK cells: critical effectors in the immune response to HIV-1
Altfeld, M., Fadda, L., Frleta, D., & Bhardwaj, N. (2011) · Nature Reviews Immunology · doi:10.1038/nri2935 · Cited by 216
Srivastava, S., Swanson, S. K., Manel, N., Florens, L., Washburn, M. P., & Skowronski, J. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000059 · Cited by 209
Cited by
Items 301–400 of 1,001
Mucosa: Key Interactions Determining Sexual Transmission of the HIV Infection
González, S. M., Aguilar-Jiménez, W., Su, R., & Rugeles, M. T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00144 · Cited by 68
“However, the activity of the antiviral peptides appears to vary at different epithelial sites, in part, due to differential expression of antiviral genes such as HBD2, HBD3, Elafin, SAMHD1, Serpina1, APOBEC3G, Trim5α, and RNase 7 (21), being highly expressed in oral epithelial cells, compared to cervical epithelial ce…”
BackgroundRudd, S. G., Tsesmetzis, N., Sanjiv, K., Paulin, C. B. J., Sandhow, L., Kutzner, J., Myrberg, I. H., Bunten, S. S., Axelsson, H., Zhang, S. M., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910419 · Cited by 64
“As demonstrated previously (Hrecka et al, 2011; Laguette et al, 2011; Herold et al, 2017b), Vpx treatment efficiently depleted SAMHD1 protein (Fig 3C and E, Appendix Fig S10C) and, in line with our data in cancer cell lines, completely abolished the RNRi-mediated sensitisation to ara-C toxicity…”
TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner
OhAinle, M., Kim, K., Keceli, S. K., Felton, A., Campbell, E., Luban, J., & Emerman, M. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008507 · Cited by 63
“The SIV−VLPs were added to transfer Vpx to the cells in order to overcome restriction by SAMHD1 against lentiviral transduction [52, 53].”
MethodAttacked from All Sides: RNA Decay in Antiviral Defense
Molleston, J. M., & Cherry, S. R. (2017) · Viruses · doi:10.3390/v9010002 · Cited by 61
“SAMHD1 was identified as a restriction factor for human immunodeficiency virus (HIV) that is antagonized by the viral protein Vpx [68].”
BackgroundBloch, N., O’Brien, M. P., Norton, T. D., Polsky, S. B., Bhardwaj, N., & Landau, N. R. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0119 · Cited by 61
“16,17 In vivo , cytokines such as IL-4 and GM-CSF that cause the maturation of myeloid cells may play a role in allowing Vpx to induce SAMHD1 degradation, analogous to what is seen in vitro with MDDCs.”
Shen, C., Jia, Y., Tian, R., Ding, M., Zhang, C., & Wang, J. (2012) · The FASEB Journal · doi:10.1096/fj.12-209023 · Cited by 61
“CD14 monocytes from HIV-1 infection, as the SAMHD1-deficient CD14 cells from individuals with Aicardi–Goutières syndrome are highly susceptible to HIV-1 infection (25), while SAMHD1 shows equivalent expression in monocytes compared with their differentiated DC counterparts (21), which suggests that SAMHD1 may not part…”
BackgroundXu, X., Qiu, C., Zhu, L., Huang, J., Li, L., Fu, W., Zhang, L., Wei, J., Wang, Y., Geng, Y., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401249 · Cited by 55
“not physiological conditions for HIV-1 infection (24), monocytes”
BackgroundGene Therapy Applications of Non-Human Lentiviral Vectors
Munis, A. M. (2020) · Viruses · doi:10.3390/v12101106 · Cited by 63
“While SIVsmm can counteract this activity via its accessory proteins Vpx [178], recently, in a study, Mereby and colleagues demonstrated that non-primate lentiviruses lacked such uniquely gained abilities [177].”
BackgroundInfluentialType I interferonopathies—an expanding disease spectrum of immunodysregulation
Lee‐Kirsch, M. A., Wolf, C., Kretschmer, S., & Roers, A. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0500-x · Cited by 61
Cyclin L2 Is a Critical HIV Dependency Factor in Macrophages that Controls SAMHD1 Abundance
Kyei, G. B., Cheng, X., Ramani, R., & Ratner, L. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.11.009 · Cited by 56
“Based on the proteins identified in the screen and those identified recently as putative DCAF1-interacting proteins (Hrecka et al., 2011; Laguette et al., 2011), we selected five gene products to test their ability to restrict or potentiate HIV replication in macrophages.”
Zhang, Y., Zhang, H., An, M., Zhao, B., Ding, H., Zhang, Z., He, Y.-W., Shang, H., & Han, X. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1706-1 · Cited by 63
SAMHD1 Host Restriction Factor: A Link with Innate Immune Sensing of Retrovirus Infection
Sze, A., Olagnier, D. P., Lin, R., van Grevenynghe, J., & Hiscott, J. B. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.10.022 · Cited by 63
“THP-1 are permissive to HIV-1 infection but can be made resistant following PMA-mediated differentiation into non-cycling macrophage-like cells [41,58,67,82,86].”
BackgroundInfluentialRuffin, N., Brezar, V., Ayinde, D., Lefebvre, C., Wiesch, J. S. Z., van Lunzen, J., Bockhorn, M., Schwartz, O., Hocini, H., Lelièvre, J., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000594 · Cited by 61
“Although SAMHD1 restriction activity toward HIV-1 infection is well established in vitro [5,6,12], its importance in the course of HIV-1 pathogenesis remains largely unknown.”
BackgroundSelf-citationBalasubramaniam, M., Pandhare, J., & Dash, C. (2019) · JoLS Journal of Life Sciences · doi:10.36069/jols/20190603 · Cited by 88
Tissue dendritic cells as portals for HIV entry
Harman, A. N., Kim, M., Nasr, N., Sandgren, K. J., & Cameron, P. U. (2013) · Reviews in Medical Virology · doi:10.1002/rmv.1753 · Cited by 62
“Recent studies have demonstrated that SAMHD1 inhibits HIV-1 infection by restricting the intracellular pool of dNTPs required for HIV replication [136,137] and that Vpx promotes DC infection by targeting SAMHD1 for proteasomal degradation [138,139].”
BackgroundAmie, S. M., Daly, M. B., Noble, E., Schinazi, R. F., Bambara, R. A., & Kim, B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.472159 · Cited by 55
“To modulate the SAMHD1 level, we treated macrophages with VLPs containing or lacking Vpx (VLPs Vpx) (20).”
Macrophages: the neglected barrier to eradication
Watters, S. A., Mlčochová, P., & Gupta, R. K. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000014 · Cited by 58
Genetics and molecular biology of brain calcification
Deng, H., Zheng, W. L., & Jankovic, J. J. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.04.004 · Cited by 57
SAMHD1: a new insight into HIV-1 restriction in myeloid cells
Gelais, C. S., & Wu, L. J. (2011) · Retrovirology · doi:10.1186/1742-4690-8-55 · Cited by 55
HERV ‐K( HML ‐2), a seemingly silent subtenant – but still waters run deep
Hanke, K., Höhn, O., & Bannert, N. (2016) · Apmis · doi:10.1111/apm.12475 · Cited by 60
Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon
Akiyama, H., Ramirez, N.-G. P., Gibson, G. A., Kline, C. E., Watkins, S. C., Ambrose, Z., & Gummuluru, S. (2017) · Journal of Virology · doi:10.1128/jvi.00972-17 · Cited by 62
“SAMHD1, whose expression can be induced by type I IFN in a cell-type-dependent manner (47, 48), can potently restrict replication of HIV-1 in macrophages (22, 24) and, therefore, may mask the effect of other ISGs on viral replication.”
BackgroundMethodMlčochová, P., Caswell, S. J., Taylor, I. A., Towers, G. J., & Gupta, R. K. (2017) · The EMBO Journal · doi:10.15252/embj.201796880 · Cited by 59
“…block is SAMHD1 dependent in macrophages We observed that lentiviruses encoding Vpx (HIV-2 and SIVsm), a SAMHD1 antagonist (Hrecka et al, 2011; Laguette et al, 2011), were insensitive to ETO in MDM suggesting that SAMHD1 might be responsible for the effect of ETO/CTH on HIV-1 infection (Fig…”
BackgroundIL-15 regulates susceptibility of CD4 + T cells to HIV infection
Manganaro, L., Hong, P. W.-P., Hernandez, M. M., Argyle, D., Mulder, L. C. F., Potla, U., Diaz‐Griffero, F., Lee, B., Fernández-Sesma, A., & Simon, V. R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806695115 · Cited by 55
“To do that, we exploited an HIV GFP reporter virus modified to incorporate Vpx (HIV*GFP-Vpx) or a mutant form of Vpx (Q76A) that does not induce SAMHD1 degradation (6, 7, 10).”
Methodde Silva, T. I., Peng, Y., Leligdowicz, A., Zaidi, I., Li, L. Q., Griffin, H., Blais, M., Vincent, T., Saraiva, M., Yindom, L. ‐., et al. (2013) · Blood · doi:10.1182/blood-2012-12-472787 · Cited by 55
Vanderford, T. H., Slichter, C. K., Rogers, K. A., Lawson, B., Obaede, R., Else, J. G., Villinger, F. J., Bosinger, S. E., & Silvestri, G. (2012) · Blood · doi:10.1182/blood-2012-02-411496 · Cited by 54
Krupp, A., McCarthy, K. R., Ooms, M., Letko, M. C., Morgan, J. S., Simon, V. R., & Johnson, W. E. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003641 · Cited by 60
“Cellular restriction factors that target replication of primate lentiviruses include A3G [17], TRIM5 a [52], BST2/Tetherin [53,54,55] and SAMHD1 [56,57].”
BackgroundHIV-1 infection–induced apoptotic microparticles inhibit human DCs via CD44
Frleta, D., Ochoa, C. E., Kramer, H., Khan, S. A., Stacey, A., Borrow, P., Kessler, B. M., Haynes, B. F., & Bhardwaj, N. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64439 · Cited by 54
“It has been shown that virus expressing Vpx can overcome this replication blockade and trigger IFN production from mDCs via a cryptic cytoplasmic sensor (38, 39).”
Guardian of the Human Genome: Host Defense Mechanisms against LINE-1 Retrotransposition
Ariumi, Y. (2016) · Frontiers in Chemistry · doi:10.3389/fchem.2016.00028 · Cited by 66
“…and SAMHD1 have been identified as restriction factors for human immunodeficiency virus type 1 (HIV-1) (Sheehy et al., 2002; Harris et al., 2003; Mangeat et al., 2003; Zhang et al., 2003; Burdick et al., 2010; Furtak et al., 2010; Wang et al., 2010; Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundInterferons Induce Expression of SAMHD1 in Monocytes through Down-regulation of miR-181a and miR-30a
Rieß, M., Fuchs, N. V., Idica, A., Hamdorf, M., Flory, E., Pedersen, I. M., & König, R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.752584 · Cited by 77
Non-human Primate Schlafen11 Inhibits Production of Both Host and Viral Proteins
Stabell, A. C., Hawkins, J., Li, M., Gao, X., David, M., Press, W. H., & Sawyer, S. L. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1006066 · Cited by 51
CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
Chen, S., Yu, X., & Guo, D. (2018) · Viruses · doi:10.3390/v10010040 · Cited by 57
“SAMHD1 is a dGTP-dependent deoxynucleoside triphosphohydrolase that reduces intracellular dNTPs below the levels required for HIV-1 reverse transcription, thereby blocking HIV-1 infection in resting CD4+ T-cells [114–117].”
BackgroundSAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity
Mauney, C. H., & Hollis, T. (2018) · Autoimmunity · doi:10.1080/08916934.2018.1454912 · Cited by 64
“of SAMHD1 to the CRL4 ubiquitin ligase complex where it is ubiquitinylated and marked for proteosomal degradation [69,146,147,153].”
BackgroundInfluentialSAMHD1 Suppression of Antiviral Immune Responses
Chen, S., Bonifati, S., Qin, Z., Gelais, C. S., & Wu, L. J. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2018.09.009 · Cited by 55
SAMHD1 Modulates Early Steps during Human Cytomegalovirus Infection by Limiting NF-κB Activation
Kim, E. T., Roche, K. L., Kulej, K., Spruce, L. A., Seeholzer, S. H., Coen, D. M., Diaz‐Griffero, F., Murphy, E. A., & Weitzman, M. D. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.027 · Cited by 59
“The sterile alpha motif (SAM) and histidine-aspartate (HD) domain-containing protein (SAMHD1) can function as a restriction factor that inhibits HIV-1 infection in non-dividing myeloid cells (Berger et al., 2011; Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundKoppensteiner, H., Höhne, K., Gondim, M. V. P., Gobert, F.-X., Widder, M., Gundlach, S., Heigele, A., Kirchhoff, F., Winkler, M., Benaroch, P., et al. (2014) · Retrovirology · doi:10.1186/1742-4690-11-1 · Cited by 54
SAMHD1 controls innate immunity by regulating condensation of immunogenic self RNA
Maharana, S., Kretschmer, S., Hunger, S., Yan, X., Kuster, D., Traikov, S., Zillinger, T., Gentzel, M., Elangovan, S., Dasgupta, P., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.08.031 · Cited by 55
Bernier, A., Cleret‐Buhot, A., Zhang, Y., Goulet, J.-P., Monteiro, P., Gosselin, A., DaFonseca, S., Wacleche, V. S., Jenabian, M.-A., Routy, J., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-160 · Cited by 56
“Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J: Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.”
BackgroundIFN-α Induces APOBEC3G, F, and A in Immature Dendritic Cells and Limits HIV-1 Spread to CD4+ T Cells
Mohanram, V., Sköld, A. E., Bächle, S. M., Pathak, S. K., & Spetz, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201184 · Cited by 59
Bermejo, M., López‐Huertas, M. R., García‐Pérez, J., Climent, N., Descours, B., Ambrosioni, J., Mateos, E., Rodríguez-Mora, S., Rus-Bercial, L., Benkirane, M., et al. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.02.002 · Cited by 57
“This effect of Dasatinib on preserving SAMHD1 antiviral function in non-activated CD4+ T cells was essential for its inhibitory activity, as Dasatinib could not inhibit the replication of HIV-1 virions carrying SIVsm Vpx, which targets SAMHD1 for proteasomal degradation [43;65].”
BackgroundSelf-citationNuclear Envelope Protein SUN2 Promotes Cyclophilin-A-Dependent Steps of HIV Replication
Lahaye, X., Satoh, T., Gentili, M., Cerboni, S., Silvin, A., Conrad, C., Ahmed‐Belkacem, A., Rodriguez, E. C., Guichou, J., Dereuddre‐Bosquet, N., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.074 · Cited by 53
Potent Inhibition of HIV-1 Replication in Resting CD4 T Cells by Resveratrol and Pterostilbene
Chan, C. N., Trinité, B., & Levy, D. N. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00408-17 · Cited by 57
“counteract antiviral components that are most active in resting or post-mitotic cells such as the HIV-2/SIV 375 Vpx protein that counteracts cellular SAMHD1 degradation of dNTP (87, 88).”
BackgroundProfiling the proteomic inflammatory state of human astrocytes using DIA mass spectrometry
Dozio, V., & Sanchez, J.-C. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1371-6 · Cited by 49
“Other IFN-inducible proteins were ADAR (also known as ADAR1) [34], DTX3L [35], TRIM25 [36], and the antiviral SAMHD1 protein, which has been extensively studied for its role in HIV infection [37, 38].”
BackgroundRuffin, N., Gea‐Mallorquí, E., Brouiller, F., Jouve, M. J., Silvin, A., See, P., Dutertre, C., Ginhoux, F., & Benaroch, P. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911007116 · Cited by 58
Virus-induced metabolic reprogramming and innate sensing hereof by the infected host
Thyrsted, J., & Holm, C. K. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.10.004 · Cited by 65
Cuadrado, E., Jansen, M. H., Anink, J. J., Filippis, L. D., Vescovi, A. L., Watts, C. K. W., Aronica, E., Hol, E. M., & Kuijpers, T. W. (2013) · Brain · doi:10.1093/brain/aws321 · Cited by 56
“Recently, data have revealed that SAMHD1 might act as a restriction factor for HIV infection (Berger et al., 2011; Hrecka et al., 2011; Laguette et al., 2011), and that TREX1 (Yan et al., 2010) and RNASEH2A (Genovesio et al., 2011) also have a role in the metabolism of HIV.”
BackgroundMarsili, G., Remoli, A. L., Sgarbanti, M., Perrotti, E., Fragale, A., & Battistini, A. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.06.001 · Cited by 56
“The recently characterized host restriction factor, SAMHD1, was identified as the factor targeted by Vpx of HIV-2 and some strains of SIV, that is able to inhibit HIV-1 infection in myeloid cells [130,131].”
BackgroundPauls, E., Badía, R., Torres‐Torronteras, J., Ruiz, A., Permanyer, M., Riveira‐Muñoz, E., Clotet, B., Martí, R., Ballana, E., & Esté, J. A. (2014) · AIDS · doi:10.1097/qad.0000000000000399 · Cited by 58
Murrell, B., Vollbrecht, T., Guatelli, J., & Wertheim, J. O. (2016) · Journal of Virology · doi:10.1128/jvi.00972-16 · Cited by 57
“In HIV, Vif neutralizes APOBEC3F and APOBEC3G, cytidine deaminases that induce hypermutation in the viral genome (4–7); the viral capsid has evolved to evade recognition by TRIM5- , which prevents viral-core uncoating (8–10); Vpx (found in simian immunodeficiency viruses and HIV-2, a less prevalent form of HIV) antago…”
BackgroundDiscrimination Between Self and Non-Self-Nucleic Acids by the Innate Immune System
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.08.004 · Cited by 49
“Later studies showed that Vpx binds to SAMHD1 and induces its degradation (Hrecka et al., 2011; Laguette et al., 2011).”
HIV-induced membraneless organelles orchestrate post-nuclear entry steps
Scoca, V., Morin, R., Collard, M., Tinévez, J.-Y., & Nunzio, F. D. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac060 · Cited by 53
HIV restriction in quiescent CD4+T cells
Zack, J. A., Kim, S. G., & Vatakis, D. N. (2013) · Retrovirology · doi:10.1186/1742-4690-10-37 · Cited by 55
Post-translational Modification-Based Regulation of HIV Replication
Chen, L., Keppler, O. T., & Scholz, C. W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02131 · Cited by 56
“Thereby, VPX interacts with the cullin4A (CUL4A)/ DNA damage binding protein 1 (DDB1) and CUL4-associated Factor 1 (DCAF1) complex (CRL4 complex), leading to ubiquitination and subsequent proteasomal degradation of SAMHD1.”
BackgroundInfluentialSERINC5 as a New Restriction Factor for Human Immunodeficiency Virus and Murine Leukemia Virus
Firrito, C., Bertelli, C., Vanzo, T., Chande, A. G., & Pizzato, M. (2018) · Annual Review of Virology · doi:10.1146/annurev-virology-092917-043308 · Cited by 57
Efficient generation of isogenic primary human myeloid cells using CRISPR-Cas9 ribonucleoproteins
Hiatt, J. B., Cavero, D. A., McGregor, M., Zheng, W., Budzik, J. M., Roth, T. L., Haas, K. M., Wu, D., Rathore, U., Meyer‐Franke, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109105 · Cited by 58
“The identification of SAMHD1 as the key restriction factor in myeloid cells that prevents efficient lentiviral transduction (Hrecka et al., 2011; Laguette et al., 2011) led directly to improved approaches for studying innate immunity and has been leveraged to generate more effective DC vaccines…”
How HIV-1 Takes Advantage of the Cytoskeleton during Replication and Cell-to-Cell Transmission
Lehmann, M., Nikolic, D. S., & Piguet, V. (2011) · Viruses · doi:10.3390/v3091757 · Cited by 57
CD4 + Memory Stem Cells Are Infected by HIV-1 in a Manner Regulated in Part by SAMHD1 Expression
Tabler, C. O., Lucera, M. B., Haqqani, A. A., McDonald, D. J., Migueles, S. A., Connors, M., & Tilton, J. C. (2014) · Journal of Virology · doi:10.1128/jvi.00324-14 · Cited by 57
Type I interferon in neurological disease—The devil from within
Hofer, M. J., & Campbell, I. L. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.03.006 · Cited by 50
“Interestingly, TREX1 [128], SAMHD1 [129–131] and RNaseH2 [132] have been implicated in”
BackgroundHIV-1 Trans Infection of CD4 + T Cells by Professional Antigen Presenting Cells
Rinaldo, C. R. (2013) · Scientifica · doi:10.1155/2013/164203 · Cited by 59
“An exciting, recently discovered mechanism by which macrophages restrict HIV-1 replication is that they express the dideoxynucleotide hydrolase SamHD1 [346, 347].”
BackgroundInnate immune sensing of HIV infection
Silvin, A., & Manel, N. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.12.003 · Cited by 54
miRNA-1236 Inhibits HIV-1 Infection of Monocytes by Repressing Translation of Cellular Factor VprBP
Ma, L., Shen, C., Cohen, É. A., Xiong, S., & Wang, J.-H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099535 · Cited by 51
“However, SAMHD1 shows comparable expression in monocytes compared with MDDCs, suggesting that VprBP-facilitated HIV-1 infection in MDDCs is not attributed to the SAMHD1 degradation induced by CUL4–DDB1–DCAF1/VprBP E3 ubiquitin protein ligase complex.”
Influentialvan Wilgenburg, B., Moore, M. D., James, W., & Cowley, S. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086071 · Cited by 57
Schaller, T., Pollpeter, D., Apolonia, L., Goujon, C., & Malim, M. H. (2014) · Retrovirology · doi:10.1186/1742-4690-11-29 · Cited by 49
The SAMHD1 dNTP Triphosphohydrolase Is Controlled by a Redox Switch
Mauney, C. H., Rogers, L. C., Harris, R. S., Daniel, L. W., Devarie‐Baez, N. O., Wu, H., Furdui, C. M., Poole, L. B., Perrino, F. W., & Hollis, T. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6888 · Cited by 54
“SAMHD1 has garnered significant attention for its antiviral properties in nondividing hematopoietic cells, where it acts as an interferon-inducible host restriction factor against viral infections, including HIV (3, 4, 18, 20, 21, 31, 33, 48, 54).”
BackgroundInfluentialWith me or against me: Tumor suppressor and drug resistance activities of SAMHD1
Herold, N., Rudd, S. G., Sanjiv, K., Kutzner, J., Myrberg, I. H., Paulin, C. B. J., Olsen, T. K., Helleday, T., Henter, J., & Schaller, T. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.05.001 · Cited by 49
Casein Kinase II Controls TBK1/IRF3 Activation in IFN Response against Viral Infection
Du, M., Liu, J., Chen, X., Xie, Y., Yuan, C., Yu, X., Sun, B., Lan, K., Chen, M., James, S. J., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402777 · Cited by 52
“Moreover, host proteins SamHD1 and Trex1 can prevent the accumulation of reversetranscribed DNA (6, 7, 9, 44, 46, 47), thus facilitating HIV to evade the recognition by DNA sensors such as cGAS and IFI16.”
BackgroundInfluentialTargeting the DNA damage response and repair in cancer through nucleotide metabolism
Helleday, T., & Rudd, S. G. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13227 · Cited by 52
Henn, D., Zhao, D., Sivaraj, D., Trotsyuk, A. A., Bonham, C. A., Fischer, K. S., Kehl, T., Fehlmann, T., Greco, A. H., Kussie, H. C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40519-z · Cited by 52
“…antigen-presenting cells (APCs), DCs naturally expressviralrestrictionfactors,suchasSAMdomainandHDdomain-containing protein 1 (SAMHD1), which allow them to deplete the cytoplasmic pool of deoxynucleoside triphosphates (dNTPs) necessary for the reverse transcription of viral genomes 64 .”
Bocharov, G. A., Черешнев, В. А., Gainova, I., Bazhan, S. I., Bachmetyev, B. A., Argilaguet, J. M., Martínez, J. P., & Meyerhans, A. (2012) · Mathematical Modelling of Natural Phenomena · doi:10.1051/mmnp/20127507 · Cited by 54
“Multiple host factors can restrict HIV [121,147,179,180,224,225, 245,250]”
BackgroundHIV-1 Replication and APOBEC3 Antiviral Activity Are Not Regulated by P Bodies
Phalora, P. K., Sherer, N. M., Wolinsky, S. M., Swanson, C. M., & Malim, M. H. (2012) · Journal of Virology · doi:10.1128/jvi.00595-12 · Cited by 50
“The APOBEC3 proteins, along with Trim5 , tetherin, and most recently, SAMHD1, have been identified as host restriction factors that have the intrinsic ability to defend against invading exogenous viruses and endogenous retroelements (45, 58, 75, 90, 92).”
BackgroundAicardi–Goutieres syndrome: from patients to genes and beyond
Chahwan, C., & Chahwan, R. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01825.x · Cited by 53
Unmasking immune sensing of retroviruses: Interplay between innate sensors and host effectors
van Montfoort, N., Olagnier, D. P., & Hiscott, J. B. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.08.006 · Cited by 54
HIV-1 Vpr Protein Inhibits Telomerase Activity via the EDD-DDB1-VPRBP E3 Ligase Complex
Wang, X., Singh, S., Jung, H.-Y., Yang, G., Jun, S., Sastry, K. J., & Park, J.-I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.416735 · Cited by 47
“Similarly, Vpx fromHIV-2 targets SAMHD1 (SAM and HD domain-containing protein 1), a viral restriction factor, via E3 ligase (7, 8).”
BackgroundImaging HIV-1 Genomic DNA from Entry through Productive Infection
Stultz, R. D., Cenker, J. J., & McDonald, D. (2017) · Journal of Virology · doi:10.1128/jvi.00034-17 · Cited by 45
“in vivo (31, 32), (ii) the cells are terminally differentiated and thus will not undergo cell division and consequent nuclear EdU incorporation, and (iii) we can control the level of deoxynucleoside triphosphates (dNTPs) in the cells by depleting sterile alpha motif and histidine/aspartic acid domain-containing protei…”
MethodAgudo, J., Ruzo, A., Kitur, K., Sachidanandam, R., Blander, J. M., & Brown, B. D. (2012) · Molecular Therapy · doi:10.1038/mt.2012.150 · Cited by 46
Quillay, H., Costa, H. E., Marlin, R., Duriez, M., Cannou, C., Chrétien, F., Fernandez, H., Lebreton, A., Ighil, J., Schwartz, O., et al. (2014) · Journal of Virology · doi:10.1128/jvi.01730-14 · Cited by 52
“HIV-1 infection is restricted by SAMHD1 in myeloid cells (28, 29) and in resting CD4 T lymphocytes (30, 31).”
BackgroundInfluentialSelf-citationRothenburger, T., McLaughlin, K.-M., Herold, T., Schneider, C., Oellerich, T., Rothweiler, F., Feber, A., Fenton, T. R., Wass, M. N., Keppler, O. T., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-1052-8 · Cited by 51
Albanese, M., Ruhle, A., Mittermaier, J., Mejías‐Pérez, E., Gapp, M., Linder, A., Schmacke, N. A., Hofmann, K., Hennrich, A. A., Levy, D. N., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01328-8 · Cited by 52
MicroRNA-Mediated Restriction of HIV-1 in Resting CD4+ T Cells and Monocytes
Chiang, K., & Rice, A. P. (2012) · Viruses · doi:10.3390/v4091390 · Cited by 50
Romani, B., Shaykh‐Baygloo, N., Hamidi-Fard, M., Aghasadeghi, M. R., & Allahbakhshi, E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.689018 · Cited by 47
Prevention of SHIV transmission by topical IFN-β treatment
Veazey, R. S., Pilch-Cooper, H. A., Hope, T. J., Alter, G., Carias, A. M., Sips, M., Wang, X., Rodriguez, B. A., Sieg, S. F., Reich, A. M., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.146 · Cited by 47
HIV Infection Stabilizes Macrophage-T Cell Interactions To Promote Cell-Cell HIV Spread
Lopez, P. G., Koh, W. H., Hnatiuk, R., & Murooka, T. T. (2019) · Journal of Virology · doi:10.1128/jvi.00805-19 · Cited by 51
“activated CD4 T cells due to high SAMHD1 expression (30, 31), their localization and”
BackgroundThe mechanism of substrate-controlled allosteric regulation of SAMHD1 activated by GTP
Zhu, C. F., Wei, W., Peng, X., Dong, Y., Gong, Y., & Yu, X.-F. (2015) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s1399004714027527 · Cited by 47
“Recently, SAMHD1 has been reported to be a potent inhibitor of retroviruses such as HIV-1 (Laguette et al., 2011; Hrecka et al., 2011; Berger et al., 2011; Roesch & Schwartz, 2013; Descours et al., 2012; Baldauf et al., 2012), DNA viruses (Hollenbaugh et al., 2013; Kim et al., 2013) and endogenous retrotransposons (Zh…”
BackgroundInfluentialG 2 /M Cell Cycle Arrest Correlates with Primate Lentiviral Vpr Interaction with the SLX4 Complex
Berger, G., Lawrence, M., Hué, S., & Neil, S. J. D. (2014) · Journal of Virology · doi:10.1128/jvi.02307-14 · Cited by 47
“SIVrcm is a member of the same lineage as SIVsmm and HIV-2, in which the vpr gene was duplicated to generate vpx, with the former retaining cell cycle arrest activity and the latter targeting SAMHD1 (8, 10, 40).”
BackgroundHIV relies on neddylation for ubiquitin ligase-mediated functions
Nekorchuk, M. D., Sharifi, H. J., Furuya, A. K. M., Jellinger, R. M., & de Noronha, C. M. C. (2013) · Retrovirology · doi:10.1186/1742-4690-10-138 · Cited by 47
“; licensee BioMed Cen Commons Attribution License (http://creativec reproduction in any medium, provided the or viruses (SIV) express Vpx to recruit SAMHD1 to the CRL4 complex and thereby trigger its ubiquitination and subsequent proteasomal degradation [2,3].”
BackgroundDefective HIV-1 genomes and their potential impact on HIV pathogenesis
Kuniholm, J., Coote, C., & Henderson, A. J. (2022) · Retrovirology · doi:10.1186/s12977-022-00601-8 · Cited by 50
Inhibition of CUL4A Neddylation Causes a Reversible Block to SAMHD1-Mediated Restriction of HIV-1
Hofmann, H., Norton, T. D., Schultz, M. L., Polsky, S. B., Sunseri, N., & Landau, N. R. (2013) · Journal of Virology · doi:10.1128/jvi.02002-13 · Cited by 46
Reinhard, C., Bottinelli, D., Kim, B., & Luban, J. (2014) · Retrovirology · doi:10.1186/1742-4690-11-12 · Cited by 50
HTLV-1 Tax impairs K63-linked ubiquitination of STING to evade host innate immunity
Wang, J., Yang, S., Liu, L., Wang, H., & Yang, B. (2017) · Virus Research · doi:10.1016/j.virusres.2017.01.016 · Cited by 46
Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics
Gutiérrez-Chamorro, L., Felip, E., Ezeonwumelu, I. J., Vila, M. M., & Ballana, E. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.01.014 · Cited by 49
No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing
Smits, N., Rasmussen, J., Bodea, G. O., Amarilla, A. A., Gerdes, P., Sanchez-Luque, F. J., Ajjikuttira, P., Modhiran, N., Liang, B., Faivre, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109530 · Cited by 52
“The higher number of L1 and Alu insertions found in our SARS-CoV-2-infected HEK293T cells is of potential interest given that viral infection can repress host factors limiting L1 activity (Hrecka et al., 2011; Laguette et al., 2011; Zhao et al., 2013).”
Nakagawa, T., Mondal, K., & Swanson, P. C. (2013) · BMC Molecular Biology · doi:10.1186/1471-2199-14-22 · Cited by 56
ADAR1 and PKR, interferon stimulated genes with clashing effects on HIV-1 replication
Radetskyy, R., Daher, A., & Gatignol, A. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.03.007 · Cited by 49
The HIV1 Protein Vpr Acts to Enhance Constitutive DCAF1-Dependent UNG2 Turnover
Wen, X., Casey Klockow, L., Nekorchuk, M., Sharifi, H. J., & de Noronha, C. M. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030939 · Cited by 41
“The same ubiquitin ligase complex is also recruited by the closely related HIV2- and SIVSM Vpx proteins to defeat an antiviral factor that blocks efficient reverse transcription in cells of the monocytic lineage [8,9,10,11].”
BackgroundBrégnard, C., Zamborlini, A., Leduc, M., Chafey, P., Camoin, L., Saïb, A., Bénichou, S., Danos, O., & Basmaciogullari, S. (2013) · Journal of Virology · doi:10.1128/jvi.02477-12 · Cited by 51
Arnold, L. H., Kunzelmann, S., Webb, M. R., & Taylor, I. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03903-14 · Cited by 47
“In addition, SAMHD1 is an anti-HIV-1 restriction factor that blocks the infection of monocyte-derived dendritic cells (MDDCs) (8), monocyte-derived macrophages (MDMs) (9), and resting T cells (10) through its triphosphohydrolase activity (2).”
Gorry, P. R., Francella, N., Lewin, S. R., & Collman, R. G. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0713368 · Cited by 49
“ferred by SAMHD1 [36, 37].”
Human cytomegalovirus overcomes SAMHD1 restriction in macrophages via pUL97
Businger, R., Deutschmann, J., Gruska, I., Milbradt, J., Wiebusch, L., Gramberg, T., & Schindler, M. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0557-8 · Cited by 51
Machida, S., Depierre, D., Chen, H., Thenin-Houssier, S., Petitjean, G., Doyen, C. M., Takaku, M., Cuvier, O., & Benkirane, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913754117 · Cited by 46
Self-citationMorris, E. R., Caswell, S. J., Kunzelmann, S., Arnold, L. H., Purkiss, A. G., Kelly, G. P., & Taylor, I. A. (2020) · Nature Communications · doi:10.1038/s41467-020-16983-2 · Cited by 48
Izumi, T., Burdick, R. C., Shigemi, M., Plisov, S. Y., Hu, W.-S., & Pathak, V. K. (2013) · Journal of Virology · doi:10.1128/jvi.02070-13 · Cited by 48
Metadata
- Authors
- Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Laguette, Nadine
- Benkirane, Monsef
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7353
- Pages
- 654-657
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3595993
- OpenAlex
- W2069554621
- Cited by
- 1,511
- References
- 27
- Citations by year
- 2026: 45 · 2025: 60 · 2024: 67 · 2023: 67 · 2022: 84 · 2021: 72 · 2020: 82 · 2019: 113 · 2018: 113 · 2017: 109 · 2016: 114 · 2015: 118 · 2014: 134 · 2013: 159 · 2012: 131
- FWCI
- 58.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- SAMHD1, HIV-1 restriction factors, Vpx, dendritic cells, myeloid cells, Aicardi-Goutières syndrome, proteasomal degradation, HIV-1 replication, viral DNA accumulation, phosphohydrolase activity, interferon response, HIV-2, simian immunodeficiency virus
- MeSH terms
- SAM Domain and HD Domain-Containing Protein 1, Cell Line, Dendritic Cells, DNA, Viral, HeLa Cells, Humans, Virus Replication, HIV-1, HIV Infections, U937 Cells, Monomeric GTP-Binding Proteins, Gene Silencing, Myeloid Cells, Proteasome Endopeptidase Complex, Viral Regulatory and Accessory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.